Considerations of biomarker application for cancer continuum in the era of precision medicine

Curr Epidemiol Rep. 2022 Sep;9(3):200-211. doi: 10.1007/s40471-022-00295-8. Epub 2022 Jul 9.

Abstract

Purpose of the review: The goal of this review is to highlight emerging biomarker research by the key phases of the cancer continuum and outline the methodological considerations for biomarker application.

Recent findings: While biomarkers have an established role in targeted therapy and to some extent, disease monitoring, their role in early detection and survivorship remains to be elucidated. With the advent of omics technology, the discovery of biomarkers has been accelerated exponentially, therefore careful consideration to ensure an unbiased study design and robust validity is crucial.

Summary: The rigor of biomarker research holds the key to the success of precision health care. The potential clinical utility and the feasibility of implementation should be central to future biomarker research study design.

Keywords: Biomarker; Cancer; Early detection; Precision medicine; Prognosis; Survivorship.